Company Filing History:
Years Active: 2010
Title: Ameet Patki: Innovator in Human Embryonic Stem Cell Research
Introduction
Ameet Patki is a prominent inventor based in Mumbai, India. He has made significant contributions to the field of stem cell research, particularly in the establishment of human embryonic stem cell lines. His work has implications for regenerative medicine and developmental biology.
Latest Patents
Ameet Patki holds a patent for the "Establishment of a human embryonic stem cell line using mammalian cells." This patent describes purified preparations of human embryonic stem cells that exhibit specific population characteristics. The preparation is characterized by the positive expression of pluripotent cell surface markers such as SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. Additionally, the cells are negative for lineage-specific markers, indicating their pluripotent nature. The embryonic stem cell line, known as Relicell™ hES1, retains the ability to differentiate into various cell and tissue types derived from all three embryonic germ layers.
Career Highlights
Ameet Patki is associated with Reliance Life Sciences Pvt. Ltd., where he continues to advance his research in stem cell technology. His work has been pivotal in understanding the characteristics and potential applications of human embryonic stem cells.
Collaborations
Ameet collaborates with notable colleagues, including Arundhati Mandal and Shabari Pradeep Tipnis, to further enhance the research and development in the field of stem cell science.
Conclusion
Ameet Patki's innovative work in human embryonic stem cell research positions him as a key figure in the scientific community. His contributions have the potential to impact various fields, including medicine and biotechnology.